Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MBGAF
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 7.00 1.35 1.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 15.30 20.25 17.57
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.81 92.23 88.00
Cash 8.45 23.00 21.21
Capex 43.03 -1.39 -2.44
Free Cash Flow 197.67 3.00 1.01
Revenue -10.51 34.55 38.61
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.07 0.20 0.20
Operating Margin -9.90 0.08 0.09
ROA -6.06 0.01 0.01
ROE -8.57 0.03 0.03
ROIC -19.26 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MBGAF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MBGAF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MBGAF is permitted for members.